Works matching IS 09255710 AND DT 2022 AND VI 116 AND IP 3
Results: 17
Peripartum management of hereditary thrombophilia: results of primary surveillance in Japan.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 364, doi. 10.1007/s12185-022-03354-4
- By:
- Publication type:
- Article
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 341, doi. 10.1007/s12185-022-03352-6
- By:
- Publication type:
- Article
Secondary chronic myeloid leukemia in a patient with CALR and ASXL1-mutated primary myelofibrosis.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 442, doi. 10.1007/s12185-022-03331-x
- By:
- Publication type:
- Article
Discordant lymphomas of classic Hodgkin lymphoma and peripheral T-cell lymphoma following dupilumab treatment for atopic dermatitis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Feasibility of ovarian stimulation for fertility preservation during and after blinatumomab treatment for Ph-negative B-cell acute lymphoblastic leukemia.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 453, doi. 10.1007/s12185-022-03323-x
- By:
- Publication type:
- Article
Relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia: an overview of prevention and treatment.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Guest editorial: prophylaxis and treatment of relapse after allogeneic hematopoietic stem cell transplantation.
- Published in:
- 2022
- By:
- Publication type:
- review
Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 315, doi. 10.1007/s12185-022-03398-6
- By:
- Publication type:
- Article
Anti-programmed cell death-1 monoclonal antibody therapy before or after allogeneic hematopoietic cell transplantation for classic Hodgkin lymphoma: a literature review.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 309, doi. 10.1007/s12185-022-03391-z
- By:
- Publication type:
- Article
FLT3-targeted treatment for acute myeloid leukemia.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 351, doi. 10.1007/s12185-022-03374-0
- By:
- Publication type:
- Article
Propensity score matching/reweighting analysis comparing autologous and allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 393, doi. 10.1007/s12185-022-03368-y
- By:
- Publication type:
- Article
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 381, doi. 10.1007/s12185-022-03367-z
- By:
- Publication type:
- Article
Longitudinal profiling of anti-factor VIII antibodies in Japanese patients with congenital hemophilia A during factor VIII replacement and immune-tolerance induction therapy.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 423, doi. 10.1007/s12185-022-03359-z
- By:
- Publication type:
- Article
Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 372, doi. 10.1007/s12185-022-03358-0
- By:
- Publication type:
- Article
A retrospective survey of patients who discontinued participation in the JPLSG HLH-2004 clinical trial.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 434, doi. 10.1007/s12185-022-03357-1
- By:
- Publication type:
- Article
MEdical Database AnaLysIS of Japanese multiple myeloma patienTs with apheresis #2 (MEDALIST-2): the impact of plerixafor use on costs and healthcare resources during mobilization and stem cell transplantation.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 411, doi. 10.1007/s12185-022-03356-2
- By:
- Publication type:
- Article
Favorable outcomes of allogeneic hematopoietic stem cell transplantation with fludarabine–bendamustine conditioning and posttransplantation cyclophosphamide in classical Hodgkin lymphoma.
- Published in:
- International Journal of Hematology, 2022, v. 116, n. 3, p. 401, doi. 10.1007/s12185-022-03355-3
- By:
- Publication type:
- Article